Marty Landon

  • CEO, BioBridge Global

 Martin “Marty” J. Landon has 30 years of experience in the health care industry. Landon has held senior positions in public and private companies and is recognized for building and leading high-performance teams and value-creating initiatives. In 2016, he joined BioBridge Global as chief executive officer. Landon serves on the board of BioMed SA and the San Antonio Medical Foundation. 

Landon began his career as an internal auditor at the University of Texas Health Science Center at San Antonio and later was an auditor for four years at public accounting firm Arthur Andersen & Co. In 1987, Landon joined Intelogic Trace, a NYSE-traded firm, where he was appointed chief financial officer. 

From 1994 to 2012, Landon was an executive at Kinetic Concepts Inc., now Acelity, a global medical device company, where he led numerous acquisitions, financial and securities transactions. He developed major process improvements and IT initiatives that contributed to extraordinary growth, culminating in a $6.3 billion leveraged buyout. During his tenure at KCI, annual revenues increased from $250 million to nearly $2 billion. 

Prior to his current role, Landon served as president and CEO of CeloNova BioSciences Inc., an early-stage, innovative medical device company that develops, manufactures and sells products with multiple vascular applications. Landon remains a member of the CeloNova board of directors. 

Landon was a Certified Public Accountant from 1984 to 2010 and received his BA in accounting from Benedictine College in Kansas. Landon is a member of the advisory council of SAMMinistries in San Antonio, Texas, chair of the UTSA Research External Advisory Council and a member of the board of visitors at Southwestern University in Georgetown, Texas. 

Elizabeth Waltman

  • Chief Operating Officer, Blood Operations
  • Executive Director, The Blood & Tissue Center Foundation

Elizabeth Waltman joined the organization in January, 2013.  Waltman manages all areas of blood operations, including the departments of donor services, donor recruitment, product management, component laboratory, hospital services and operations integration, as well as the Victoria facility.  

With over 17 years of experience in executive management, Waltman has previously held positions in recruitment, quality assurance, corporate communications and project management. Most recently, she has worked in management roles with Blood Systems, Inc. and was previously with Gulf Coast Regional Blood Center. She began her career in the health care industry as a nurse in labor and delivery.

Waltman has a Masters in Business Administration from the University of Phoenix and a Bachelor of Arts from University of St. Thomas. She is the South Central Association of Blood Banks (SCABB) Foundation Treasurer and is an active member in the American College of Healthcare Executives, the American Blood Bank Society as well as other professional health care organizations.

Ward Carter

  • Chief Operating Officer, QualTex Laboratories

Ward Carter was named COO of QualTex Laboratories in February 2016. Carter had more than 31 years of experience in the laboratory diagnostics division with Abbott Laboratories, with a longtime emphasis on sales, sales management, product development, commercial operations and customer service.  He was responsible for implementing new commercial sales and marketing processes specific to customer contract and pricing development, along with ongoing customer contract and entitlement management.  Carter was also directly involved in development of commercial compliance initiatives, including customer reporting processes and new ethics and compliance guidelines specifically for the commercial organization.

At numerous points during his career with Abbott, Carter was directly involved in working with blood bank donor screening and safety testing customers, as well as with high-volume diagnostics testing laboratories. Prior to his retirement from Abbott Laboratories, Carter had general management responsibility for the US Transfusion business for Abbott Diagnostics Division.

Carter was the recipient of numerous sales, marketing, and operations awards during his tenure with Abbott, including receiving the Abbott Chairman’s Award, which was directly related to developing and negotiating a large national contract for blood donor testing.  The operations awards received recognized his ability to develop new procedures, and execute changes effectively, while maintaining and building customer satisfaction and loyalty. 

At QualTex, Carter has been instrumental in expanding the capacity footprint and introducing new products and services that expand the customer service offering, while at the same time ensuring that quality is core to everything the QualTex team delivers.

With facilities in San Antonio and Atlanta, QualTex Laboratories is one of the largest independent nonprofit biologic testing centers in the United States. It performs advanced testing services for blood, plasma and tissue donations, as well as testing to support cellular therapy and cell manufacturing, in addition to reference testing and clinical research.  As of January 2018, QualTex Atlanta is the first blood, tissue and plasma collection biologic safety testing laboratory to implement a fully automated sample management system.

Becky Butler Cap

Becky Butler Cap

  • Chief Operating Officer, GenCure

Becky Cap, a 20-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February, 2016.  GenCure, a subsidiary of BioBridge Global, is focused on providing and developing regenerative medicine and cellular therapy products.  GenCure’s mission is to realize the potential of donated human cells and tissue to save and enhance lives.

Cap, a native of Texas, earned a bachelor’s degree from Harvard University. She began her career at Dana-Farber Cancer Institute in Boston, where she gained clinical, laboratory and regulatory experience. 

While pursuing her MBA at Boston University’s Health Care Management Program, she moved to industry and began working for Eidetics, a consulting firm focused on informing biomedical product development, where her focus was largely on oncology product development.  She also has run her own consulting firm and worked with a number of local startups.

Cap has provided strategic guidance for the development of pharmaceuticals and extensive entrepreneurial coaching.  She is an active member of local and national committees on Regenerative Medicine and Cell Therapy.  Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.